Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNST

Constellation Pharmaceuticals (CNST) Stock Price, News & Analysis

Constellation Pharmaceuticals logo

About Constellation Pharmaceuticals Stock (NASDAQ:CNST)

Advanced Chart

Key Stats

Today's Range
$33.99
$33.99
50-Day Range
$33.63
$33.99
52-Week Range
$17.00
$39.30
Volume
N/A
Average Volume
940,325 shs
Market Capitalization
$1.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CNST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Constellation Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CNST Stock News Headlines

Plc Gsk's Net Worth
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.tc pixel
VHCP Management II, LLC's Net Worth
Constellation Software
See More Headlines

CNST Stock Analysis - Frequently Asked Questions

Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) posted its quarterly earnings results on Sunday, May, 9th. The company reported ($0.84) earnings per share for the quarter, missing the consensus estimate of ($0.79) by $0.05.

Constellation Pharmaceuticals (CNST) raised $80 million in an initial public offering on Thursday, July 19th 2018. The company issued 5,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Jefferies and BMO Capital Markets served as the underwriters for the IPO and Oppenheimer was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Constellation Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Kinross Gold (KGC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Axsome Therapeutics (AXSM), Gilead Sciences (GILD) and OPKO Health (OPK).

Company Calendar

Last Earnings
5/09/2021
Today
8/23/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CNST
CIK
29806
Fax
N/A
Employees
154
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$126.36 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.12%
Return on Assets
-29.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.39
Quick Ratio
15.39

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.63 per share
Price / Book
3.94

Miscellaneous

Outstanding Shares
47,915,000
Free Float
N/A
Market Cap
$1.63 billion
Optionable
Not Optionable
Beta
2.59

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:CNST) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners